Tonghua Dongbao Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 600867.SS

Tonghua Dongbao Pharmaceutical Co., Ltd. Free Cash Flow for the year ending December 31, 2023: USD 72.31 M

Tonghua Dongbao Pharmaceutical Co., Ltd. Free Cash Flow is USD 72.31 M for the year ending December 31, 2023, a 34.34% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Tonghua Dongbao Pharmaceutical Co., Ltd. Free Cash Flow for the year ending December 31, 2022 was USD 53.83 M, a -35.92% change year over year.
Tonghua Dongbao Pharmaceutical Co., Ltd. Free Cash Flow for the year ending December 31, 2021 was USD 84.01 M, a -23.06% change year over year.
Tonghua Dongbao Pharmaceutical Co., Ltd. Free Cash Flow for the year ending December 31, 2020 was USD 109.18 M, a -11.49% change year over year.
Tonghua Dongbao Pharmaceutical Co., Ltd. Free Cash Flow for the year ending December 31, 2019 was USD 123.36 M, a 716.82% change year over year.

Key data

Date	Free Cash Flow	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities

Shanghai Stock Exchange: 600867.SS

Tonghua Dongbao Pharmaceutical Co., Ltd.

CEO	Mr. Sheng Leng Chun
IPO Date	Aug. 24, 1994
Location	China
Headquarters	Dongbao New Village
Employees	3,196
Sector	Healthcare
Industries Pharmaceuticals 3D Printing Biotechnology Composite Materials Drugstores & Retail Pharmacies Eyewear Non-Alcoholic Beverages Plastics

Description

Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products for the treatment of diabetes and cardiovascular-based diseases in China. The company operates through Pharmaceutical Industry and Building Materials Industry segments. Its lead product portfolio includes insulin analogues, such as insulin glargine, Insulin aspart, and insulin lispro; antidiabetic drugs; and oral hypoglycemic drugs, as well as Gan Shulin pens, blood glucose meters, and other medical devices. It offers building materials. The company has a strategic alliance with Adocia. Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is based in Tonghua, China.

Key trends

Past 5 years